Document is current
Any future updates will be listed below
-
Authors
Fortuno, Cristina
Frone, Megan N.
Mester, Jessica
de la Hoya, Miguel
Mai, Phuong L.
Pesaran, Tina
Achatz, Maria Isabel
Bassett, Rebecca
Bustamante, Carolina
Crowley, Stephanie
de Andrade, Kelvin Cesar
Evans, D. Gareth
Feng, Bingjian
Fuqua, Laura
Harrell, Maria Isabel
Hatton, Jessica N.
Huether, Robert
Kesserwan, Chimene
Lee, Kristy
MacFarland, Suzanne P.
Maciaszek, Jamie L.
Maxwell, Kara
McGoldrick, Kelly
Murphy, Maureen
Nehoray, Bita
Penkert, Judith
Pinto, Emilia Modolo
Plon, Sharon E.
Schwartz-Levine, Alison
Thompson, Ashley S.
Wang, Wenyi
Zambetti, Gerard P.
Zelley, Kristin
James, Paul A.
Savage, Sharon A.
Kratz, Christian P.
Spurdle, Amanda B.
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 20 August 2025
First Online: 22 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: The following authors work for laboratories that offer fee-for-service testing: RH, CB, SC, LF, KM, MIH, JM, TP. The following authors have made substantial contributions to the TP53 gene-disease literature: CF, PAJ, ABS, MNF, SAS, EMP, GPZ, DGE. MNF receives royalties for product development of CancerGene Connect from Ommdom, Inc. DGE has received consultancy fees from Everything genetic Ltd. All other authors declare that they have no competing interests.
